tp500 bpc 157 BPC-157 + TB-500 Peptides BPC-157 5mg + TB-500 5mg

Wang L, Shi X, Zhao R, Halloran BP, Clark DJ, Jacobs CR, et al

Gene Expression Analysis Gene expression analysis revealed overlapping patterns between ketamine and BPC-157 effects on Nos1 (neuronal NOS), Nos2 (inducible NOS), Plcg1, Prkcg, and Ptgs2 (COX-2)

Interestingly, working memory is considered to have a strong genetic component based on the DRD1 gene variants.[ref] DRD2 receptor: The DRD2 receptor is less abundant in the cerebral cortex than the DRD1 receptor, but it is abundant in other areas of the brain with dopaminergic neurons

The TB-500 effect follows, with improvements in overall mobility and functional capacity emerging several weeks later